Warehouse-native access is emerging as the fastest, safest path to unified customer intelligence. It isn't without its challenges.

Third time’s the charm? Microsoft hopes the scalability of Azure HorizonDB, will lure new customers where its two existing ...

With the official release of Microsoft's latest database offering, let's see what was improved and what still needs some work ...

Microsoft made a series of database announcements at the Ignite conference, including the general availability of SQL Server ...

During QCon SF, Jeremy Edberg and Qian Li from DBOS presented a non-conventional architectural approach to workflow ...

Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal hemoglobin (HbF) in adult patients with SCD Iadademstat has demonstrated a favorable ...

European Heart Journal publishes SCD-PROTECT study, addressing evidence gap in early SCD risk in the context of four-pillar GDMT for both NICM and MI/CAD patients ZOLL®, an Asahi Kasei company that ...

81.7% of patients were on an SGLT2 inhibitor 74.7% of patients were on an ARNI 95.1% of patients were on a beta-blocker 83.1% of patients were on an MRA Despite high use of GDMT, the rate of ...

Pfizer’s sickle cell disease (SCD) drug has flunked a key phase 3 test, the latest blow to the pharma’s $5.4 billion acquisition of Global Blood Therapeutics. Pfizer acquired the P-selectin inhibitor, ...

The Zuckerberg College of Health Sciences, Department of Public Health, invites you to attend a doctoral dissertation defense by Kaylea Flangan, MPH, RD on “Ultra-Processed Food Consumption, Cognitive ...